HK Stock MarketDetailed Quotes
02257 SIRNAOMICS-B
- 6.060
- 0.0000.00%
Pre-Opening Auction Apr 26 09:09 CST
531.09MMarket Cap-863P/E (TTM)
0.000High0.000Low0Volume0.000Open6.060Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)87.64MShares59.00052wk High1.69P/B531.09MFloat Cap5.64052wk Low--Dividend TTM87.64MShs Float101.000Historical High--Dividend LFY0.00%Amplitude5.640Historical Low--Avg Price50Lot Size--Div YieldTTM--Div Yield LFY
SIRNAOMICS-B Key Stats
All
YOY
| (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | (FY)Dec 31, 2020 | (Q9)Sep 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating income | |||||||||
| Operating expenses | |||||||||
| Gross profit | |||||||||
| Administrative expenses | 4.26%-23.16M | 2.63%-10.82M | -50.07%-24.19M | ---11.11M | -212.58%-16.12M | -129.77%-8.41M | -10.50%-5.16M | ---3.66M | ---4.67M |
| Research and development expenses | 19.60%-54.38M | 4.36%-30.71M | -66.30%-67.64M | ---32.11M | -173.08%-40.67M | -124.31%-22.01M | -45.83%-14.89M | ---9.81M | ---10.21M |
| Revaluation surplus | 79.23%-1.27M | 90.06%-286K | 95.81%-6.12M | ---2.88M | -730.99%-146.04M | 33.69%-13.11M | -580.11%-17.57M | ---19.77M | ---2.58M |
| -Changes in the fair value of financial assets | 5,925.00%241K | --155K | --4K | ---- | ---- | 33.69%-13.11M | ---- | ---19.77M | ---2.58M |
| -Changes in the fair value of other assets | 75.31%-1.51M | 84.67%-441K | 95.81%-6.12M | ---2.88M | -730.99%-146.04M | ---- | ---17.57M | ---- | ---- |
| Impairment and provision | ---8.35M | ---- | ---- | ---- | ---- | ---- | 200.00%242K | ---- | ---242K |
| -Impairment of property, machinery and equipment | ---8.35M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | ---- | ---- | ---- | ---- | ---- | ---- | 200.00%242K | ---- | ---242K |
| Special items of operating profit | 129.96%3.16M | 214.91%1.16M | 110.75%1.37M | --369K | -45.01%-12.76M | -2,208.08%-6.26M | -1,189.36%-8.8M | --297K | --808K |
| Operating profit | 13.02%-84M | 11.10%-40.65M | 55.20%-96.58M | -45.72M | -366.81%-215.6M | -51.13%-49.8M | -173.32%-46.19M | -32.95M | -16.9M |
| Financing cost | -23.56%-986K | -21.81%-458K | -135.40%-798K | ---376K | -39.51%-339K | -9.78%-202K | -6.11%-243K | ---184K | ---229K |
| Earning before tax | 12.72%-84.99M | 10.83%-41.11M | 54.90%-97.38M | -46.1M | -365.09%-215.93M | -50.90%-50M | -171.08%-46.43M | -33.14M | -17.13M |
| After-tax profit from continuing operations | 12.72%-84.99M | 10.83%-41.11M | 54.90%-97.38M | -46.1M | -365.09%-215.93M | -50.90%-50M | -171.08%-46.43M | -33.14M | -17.13M |
| Earning after tax | 12.72%-84.99M | 10.83%-41.11M | 54.90%-97.38M | -46.1M | -365.09%-215.93M | -50.90%-50M | -171.08%-46.43M | -33.14M | -17.13M |
| Minority profit | 30.62%-6.3M | 25.43%-3.15M | -217.11%-9.08M | ---4.22M | -7.79%-2.86M | -62.46%-1.93M | -256.03%-2.66M | ---1.19M | ---746K |
| Profit attributable to shareholders | 10.88%-78.69M | 9.36%-37.96M | 58.56%-88.3M | -41.88M | -386.77%-213.07M | -50.47%-48.07M | -167.21%-43.77M | -31.95M | -16.38M |
| Basic earnings per share | 11.21%-1.03 | 9.09%-0.5 | 91.89%-1.16 | -0.55 | -351.10%-14.3 | -41.88%-3.32 | -138.35%-3.17 | -2.34 | -1.33 |
| Diluted earnings per share | 11.21%-1.03 | 9.09%-0.5 | 91.89%-1.16 | -0.55 | -351.10%-14.3 | -41.88%-3.32 | -138.35%-3.17 | -2.34 | -1.33 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg